{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T05:53:20Z","timestamp":1758174800009,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.amjms.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T11:06:04Z","timestamp":1749812764000},"page":"347-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of inhaler treatments on respiratory functions and exacerbation frequency in non-cystic fibrosis bronchiectasis"],"prefix":"10.1016","volume":"370","author":[{"given":"U\u011fur","family":"Fidan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"K\u0131z\u0131l\u0131rmak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ay\u015f\u0131n","family":"\u015eakar Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.amjms.2025.06.008_bib0001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.disamonth.2008.05.007","article-title":"Bronchiectasis: introduction, etiology, and clinical features","volume":"54","author":"Baydarian","year":"2008","journal-title":"Dis Mon"},{"key":"10.1016\/j.amjms.2025.06.008_bib0002","first-page":"1","article-title":"Bronchiectasis: epidemiology and causes","volume":"52","author":"Bilton","year":"2011","journal-title":"Eur Respir Mon"},{"issue":"18","key":"10.1016\/j.amjms.2025.06.008_bib0003","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"Bronchiectasis","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.008_bib0004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.amjms.2025.06.008_bib0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/jcm5120115","article-title":"Bronchiectasis in the Last Five Years: NewDevelopments","volume":"5","author":"Khoo","year":"2016","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.008_bib0006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/mjac14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.008_bib0007","article-title":"Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","author":"Ducharme","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0008","article-title":"Inhaled steroids for bronchiectasis","author":"Kapur","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.008_bib0009","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s11096-012-9659-6","article-title":"Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis","volume":"34","author":"Hernando","year":"2012","journal-title":"Int J Clin Pharm"},{"issue":"9842","key":"10.1016\/j.amjms.2025.06.008_bib0010","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.amjms.2025.06.008_bib0011","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.008_bib0012","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pupt.2009.06.002","article-title":"Alternative mechanisms for tiotropium","volume":"22","author":"Bateman","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.amjms.2025.06.008_bib0013","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.008_bib0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.008_bib0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thx.2002.003236","article-title":"Inhaled fluticasone in bronchiectasis: a 12 month study","volume":"60","author":"Tsang","year":"2005","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.21037\/jtd-20-1282","article-title":"Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study","volume":"13","author":"Lee","year":"2021","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.06.008_bib0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/0970-258X.310987","article-title":"Bronchiectasis in India: Results from the EMBARC and Respiratory Research Network of India Registry","volume":"33","author":"Hariprasad","year":"2020","journal-title":"Natl Med J India"},{"issue":"4","key":"10.1016\/j.amjms.2025.06.008_bib0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0021","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.008_bib0022","article-title":"Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects","volume":"46","author":"Nucci","year":"2020","journal-title":"J Bras Pneumol"},{"issue":"3","key":"10.1016\/j.amjms.2025.06.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"Supl 1","key":"10.1016\/j.amjms.2025.06.008_bib0024","first-page":"1","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.arbr.2020.11.010","article-title":"RIBRON: The spanish Online Bronchiectasis Registry. Characterization of the First 1912 Patients. RIBRON: el registro espa\u00f1ol informatizado de bronquiectasias. Caracterizaci\u00f3n de los primeros 1.912 pacientes","volume":"57","author":"Martinez-Garc\u00eda","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)"},{"issue":"9","key":"10.1016\/j.amjms.2025.06.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30327-4","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"6","key":"10.1016\/j.amjms.2025.06.008_bib0027","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00408-019-00280-x","article-title":"Management of Australian Adults with Bronchiectasis in TertiaryCare:Evidence-Basedor Access-Driven?","volume":"197","author":"Visser","year":"2019","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.amjms.2025.06.008_bib0028","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1378\/chest.11-1484","article-title":"Bronchiectasis in patients with COPD: a distinct COPD phenotype?","volume":"140","author":"O'Donnell","year":"2011","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1370\/afm.1714","article-title":"Clinical relevance of fixed ratio vs lower limit of normal of FEV1\/FVC in COPD: patient-reported outcomes from the CanCOLD cohort","volume":"13","author":"Van Dijk","year":"2015","journal-title":"Ann Fam Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.06.008_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1465-9921-13-13","article-title":"GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study","volume":"13","author":"G\u00fcder","year":"2012","journal-title":"Respir Res"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:43:28Z","timestamp":1758048208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925010742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0002962925010742"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of inhaler treatments on respiratory functions and exacerbation frequency in non-cystic fibrosis bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}